Pediatric Intravenous Contrast-Enhanced Ultrasound(CEUS) in China
Recruiting now
Conditions studied: Abdominal Neoplasm, Abdominal Injury, Ascites
In brief
The goal of this clinical trial is to evaluate the application of intravenous contrast-enhanced ultrasound examination in children with intra-abdominal diseases that require clear diagnoses. The main questions it aims to answer are: * Is intravenous contrast-enhanced ultrasound helpful for the diagnosis of intra-abdominal diseases in children? * What medical problems do participants have when participating in intravenous contrast-enhanced ultrasound examination? * How can ultrasound doctors conduct intravenous contrast-enhanced ultrasound examinations in a standardized manner? Researchers will performing intravenous contrast-enhanced ultrasound examinations on participants and collecting research subjects to establish a multicenter clinical data database. Participants will: * Perform abdominal ultrasound examination to assess the condition. * At least conduct one intravenous contrast-enhanced ultrasound examination. Based on the result of the contrast examination, decide whether to conduct another examination. * Keep a diary of their symptoms and therapeutic process in 30 days.
Key facts
- Study ID
- NCT07113808
- Run by
- The Children's Hospital of Zhejiang University School of Medicine
- People needed
- 108
- Starts
- 2024-09-10
- Expected to finish
- 2026-09-30
- Last updated by the study team
- 2025-12-08
Who can join
Age: 0 and older, up to 18. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 29 days to 18 years old;
- The clinical diagnosis was abdominal space-occupying lesions, blunt abdominal trauma, ascites of unknown cause, and children with suspected abdominal disease but other examinations could not identify the cause.
You may not qualify if…
- Allergic to sulfur hexafluoride or other components;
- Heart disease with right-to-left shunt/severe pulmonary hypertension /uncontrolled systemic hypertension/respiratory failure/heart failure/severe arrhythmia;
- Electrocardiogram, echocardiography or clinical manifestations of myocardial ischemia;
- Patients with severe blood system diseases or infectious diseases;
- Hypercoagulable state and recent history of thrombosis;
- Severe hepatic and renal insufficiency;
- Patients with respiratory tract infection or congenital respiratory malformation.
Where it is running
- Children's Hospital, Zhejiang University School of Medicine — Hangzhou, Zhejiang, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.